Citius Pharmaceuticals
CTXR
CTXR
74 hedge funds and large institutions have $20.5M invested in Citius Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 13 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.05% more ownership
Funds ownership: 0.63% → 0.68% (+0.05%)
0% more funds holding
Funds holding: 74 → 74 (0)
Holders
74
Holding in Top 10
–
Calls
$90K
Puts
$44K
Top Buyers
| 1 | +$650K | |
| 2 | +$508K | |
| 3 | +$312K | |
| 4 |
Barclays
London,
United Kingdom
|
+$111K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$79.1K |
Top Sellers
| 1 | -$136K | |
| 2 | -$105K | |
| 3 | -$76.3K | |
| 4 |
Renaissance Technologies
New York
|
-$61K |
| 5 |
Goldman Sachs
New York
|
-$46.7K |